News

New nanotechnology from the AIBN labs could help an emerging and non-invasive cancer treatment become even more effective.

You’ll find it in potatoes, bread, and rice, and maybe in a freshly ironed shirt. Now researchers from the AIBN are examining how starch could be a key ingredient in a new generation of bioplastics.

AIBN researchers have won funding to examine if particles in our muscles could unlock new treatments for Motor Neurone Disease.

Associate Professor Joy Wolfram has won funding to help patients bounce back more effectively after open-heart surgery.

Dr Miaoqiang Lyu is working on an ink formula that could screen print better zinc batteries: flexible power sources that are stronger, cheaper and – crucially - rechargeable.

Researchers at the AIBN are harnessing bacteria to recover valuable materials and help clean up mining waste.

Cheaper and more efficient solar cells for households and commercial applications are a step closer thanks to new research that will help prove the stability and longevity of this emerging technology.

Queensland researchers and farmers are teaming up to design nanotechnology that repurposes agricultural waste into high-value soil products.

Nissa Carrodus has trained countless students in the ways of the lab over her 15 years as a research assistant. Now she’s starting a PhD of her own.

AIBN researchers have secured a major grant to position lignin as a key plank in the $15 billion market for sustainable rubbers, adhesives, and coatings.

With the support of the Lily Foundation, University of Cambridge Neurologist Dr Jelle van den Ameele and AIBN group leader Dr Seth Cheetham are hoping to change the fortunes of those born with a fatal condition.

From paper aeroplanes to angry polymers and antimicrobial coatings, AIBN research rose to the top during UQ's Three Minute Thesis (3MT) competition in 2024.

Researchers from the AIBN have made a significant step towards enabling women with epilepsy safer access to a common anti-seizure medication.

Organoid researchers at the AIBN have won $4.1 million MRFF grant to prove the effectiveness of epilepsy drugs made from spider venom.

A fresh round of Advance Queensland funding will help AIBN researchers team up with industry to develop next-gen lithium-ion batteries, indoor solar panels, and nanotech-assisted kits for drug screening.

The threat of climate change – the saying goes – is like a frog stuck in a rapidly heating pot of water...

AIBN researchers are removing harmful ‘forever chemicals’ from the environment and repurposing them in renewable batteries.

AIBN researchers are looking at how polymer tadpoles could help improve integrin-targeted therapy for certain cancer stem cells.

Researchers from The University of Queensland are using synthetic biology to help the world’s biggest businesses transition to net zero.

Dr Samantha Stehbens says a cell's journey through crowded tissue environments remains shrouded in mystery. In Nature Cell Biology, she may have some new answers.